Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Identify effective ways to increase income to pay off debt. Maximize your earnings and take control of your financial future.
22,636 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
CoreWeave delivered stronger top-line growth but a widening loss and cautious quarterly guidance. Investors reacted w...
Iren is pursuing a bold AI infrastructure push with a $4.4 billion target. This article breaks down what that means f...
A high-profile story about cautious texting reveals universal money lessons. This article translates that caution int...
A practical guide to understanding Fuel Tech (FTEK) in 2025. Learn what to watch in Q4 results, identify catalysts, a...
Figure Technology Solutions agrees to purchase Kiavi for $717 million, expanding first-lien volume by about 40% and b...
Markets tumble and bond yields rise as the president reveals European support for action against Iran is thinner than...
As Rocket Lab broadens beyond launches into aerospace and defense, a renewed thesis supports a potential growth path ...
Markets react to a rising sense that Iran is turning more effective in regional clashes, pressing U.S. allies to reth...
A recent insider move at Lindblad Expeditions Holdings drew attention from investors. This article breaks down what h...
A top AI stock has pulled back while earnings surge, drawing attention from analysts who see significant upside ahead...
Redwire shares have tumbled, leaving investors wondering if the decline is temporary or a warning. This guide explain...